Shanghai Xinke Pharmaceutical Co., Ltd.

Shanghai Xinke Pharmaceutical Co., Ltd. is located in Xinzhuang Industrial Zone, Shanghai, and started business in 1995. The main business scope of the company is: research and production of radiopharmaceuticals for in vivo use (radioactive imaging agent, urea [14C] breath test capsule and kit, radioactive seed source for cancer treatment), provision of scientific and technological consultation, technical services, and sale of self-manufactured products, etc.

Since its establishment nearly 25 years ago, the company has always adhered to the tenet of “services make a difference”, continuously put in efforts, pioneered and developed, introduced the advanced technology and management model of Global Medical Solutions, Ltd., filled up the gap in the centralized production and supply of radiopharmaceuticals and broke through the traditional mode of supply of radiopharmaceuticals in China. With respect to the company’s qualifications, it has successfully obtained the radioactive production license, radioactive operation license and GMP certificate.

From 2016 to 2018, the company was successively listed as the top 100 companies in Xinzhuang Industrial Zone, Shanghai. From 2018 to 2020, it was awarded the title of “specialized, fine, special and new” small and medium enterprise issued by the Economic and Information Technology Commission of Shanghai.